The role of cancer stem cells (CD133+) in malignant gliomas

Cell Transplantation

Volumn 20, Issue 1, 2011, Pages 121-125

  Cho, Der Yang ^a,b   Lin, Shinn Zong ^a,b   Yang, Wen Kuang ^a   Hsu, Den Mei ^a   Lin, Hung Lin ^a   Lee, Han Chung ^a   Lee, Wen Yeun ^a   Chiu, Shao Chih ^b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cancer stem cells (CSCs); CD133+; Glioblastoma multiforme (GBM); Malignant gliomas; Micro RNA (miRNA); Signaling pathway

Indexed keywords

ACETYLSALICYLIC ACID; CD133 ANTIGEN; CERAMIDE; CYCLOPAMINE; IBUPROFEN; MICRORNA; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL ISOLATION; GLIOBLASTOMA; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

ANTIGENS, CD; GLIOMA; GLYCOPROTEINS; HUMANS; IMMUNOTHERAPY; MICRORNAS; NEOPLASTIC STEM CELLS; PEPTIDES; RADIATION-SENSITIZING AGENTS; SIGNAL TRANSDUCTION;

EID: 79952498450     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X532774     Document Type: Review

References (43)

1. Akasaki, Y.; Black, K. L.; Yu, J. S. Dendritic cell-based immunotherapy for malignant gliomas. Expert Rev. Neurother. 5:497-508; 2005.
2. Bao, S.; Wu, Q.; McLendon, R. E.; Hao, Y.; Shi, Q.; Hjelmeland, A. B. Glioma stem cell promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-760; 2006.
3. Bar, E. E.; Chaudhry, A.; Lin, A.; Fan, X.; Schreck, K.; Matsui, M.; Piccirillo, S.; Vescovi, A. L.; Dimeco, F.; Olivi, A.; Eberhart, C. G. Cyclopamine-mediated hedge-hog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25:2524-2533; 2007.
4. Bleau, A. M.; Howard, B. M.; Taylor, L. A.; Gursel, D.; Greenfield, J. P.; Lim Tung, H. Y.; Holland, E. C.; Boockvar, J. A. New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans. Neurosurg. Focus 24:E27; 2008.
5. Casper, D.; Lekhuaj, R.; Yaparpalvi, U. S.; Pidel, A.; Jaggernauth, W. A.; Werner, P.; Tribius, S.; Rowe, J. D.; LaSala, P. A. Acetaminophen selectively reduces glioma cell growth and increases radiosensitivity in culture. J. Neurooncol. 46:215-229; 2000.
6. Chang, C. J.; Hsu, C. C.; Yung, M. C.; Chen, K. Y.; Tzao, C.; Wu, W. F.; Chou, H. Y.; Lee, Y. Y.; Lu, K. H.; Chiou, S. H.; Ma, H. I. Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression. Biochem. Biophys. Res. Commun. 380:236-242; 2009.
7. Chang, T. A.; Morin, P. T.; Vogelstein, B.; Kinzler, K. W. Mechanisms underlying nonsteroidal antiflammatory drug-mediated apoptosis. Proc. Natl. Acad. Sci. USA 95:681-686; 1998.
8. Chinnayan, P.; Wang, M.; Rojiani, A. M.; Tofilon, P. J.; Chakravarti, A.; Ang, K. K.; Zhang, H. Z.; Hammond, E.; Curran, Jr., W. C.; Mehta, M. P. The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the radiation therapy oncology group. Radiat. Oncol. 3:32; 2008.
9. Cho, D. Y.; Lin, S. Z.; Yang, W. K.; Hsu, S. M.; Lee, H. C.; Lee, W. Y.; Liu, S. P. Dendritic cells (DCs)-based immunotherapy for malignant gliomas. Cell Transplant. 18:977-983; 2009.
10. Clement, V.; Sanchez, P.; de Tribolet, N.; Radovanovic, I.; Altaba, A. R. HEDGEHOG-GLI1 signaling regulated human glioma growth, cancer stem cell renewal and tumorigenicity. Curr. Biol. 23:165-172; 2007.
11. Davis, F. G.; Frees, S.; Grutsch, J.; Barlas, S.; Brem, S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: An analysis base on surveillance, epidemiology, end results (SEER) data 1973-1991. J. Neurosurg. 88:1-10; 1998
12. Ehtesham, M.; Mapara, K. Y.; Stevenson, C. B.; Thompson, R. C. CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Lett. 18:305-312; 2009.
13. Fan, X.; Mastsui, W.; Khaki, L. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res. 66:7445-7452; 2006.
14. Fan, X.; Salford, L. G.; Widegren, B. Glioma stem cell: Evidence and limitation. Semin. Cancer Biol. 17:214-218; 2007.
15. Gal, H.; Makovitzki, A.; Amariglio, N.; Rechavi, G.; Ram, Z.; Givol, D. A rapid assay for drug sensitivity of glioblastoma stem cells. Biochem. Biophys. Res. Commun. 358:908-913; 2007.
16. Gal, H.; Pandi, G.; Kanner, A. A.; Ram, Z.; Lithwick-Yanai, G.; Amariglio, N.; Rechavi, G.; Givol, D. MIR-451 and Imatinib mesylate inhibit tumor growth of glioblastoma stem cells. Biochem. Biophys. Res. Commun. 376:86-90; 2008.
17. Hide, T.; Takezaki, T.; Nakamura, H.; Kuratsu, J.; Kondo, T. Brain tumor stem cells as research and treatment targets. Brain Tumor Pathol. 25:67-72; 2008.
18. Joo, K. M.; Kim, S. Y.; Jin, X.; Song, S. Y.; Kong, D. S.; Lee, J. I.; Jeon, J. W.; Kim, M. H.; Kang, B. G.; Jung, Y.; Jin, J.; Hong, S. C.; Park, W. Y.; Lee, D. S.; Kim, H.; Nam, D. H. Clinical and biological implications of CD 133-positive and CD 133-negative cells in glioblastomas. Lab. Invest. 88:808-815; 2008.
19. Kang, M. K.; Hur, B. I.; Kim, C. H.; Cha, S. H.; Kang, S. K. Potential identify of multi-potential cancer stem-like subpopulation after radiation of cultured brain glioma. BMC Neurosci. 9:15; 2008.
20. Kang, M. K.; Kang, S. K. Pharmacologic blockade of chloride channel synergistically enhances apoptosis of chemotherapeutic drug-resistant cancer stem cells. Biochem. Biophys. Res. Commun. 373:539-544; 2008.
21. Kang, M. K.; Kang, S. K. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev. 16:837-847; 2007.
22. Kelly, K. A.; Kirkwood, J. M.; Kapp, D. S. Glioblastoma multiforme: Pathology, natural history and treatment. Cancer Treat. Rev. 11:1-26; 1984.
23. Kobayashi, N.; Navarro-Alvarez, N.; Soto-Gutierrez, A.; Kawamoto, H.; Kondo, Y.; Yatsuji, T.; Shirakawa, Y.; Naomoto, Y.; Tanaka, N. Cancer stem cell research: Current situation and problems. Cell Transplant. 17:19-25; 2008.
24. Liu, G.; Yuan, X.; Zeng, Z.; Tunici, P.; Ng, H.; Abdulkadir, I. R.; Lu, L.; Irvin, D.; Black, K. L.; Yu, J. S. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 5:67; 2006.
25. Lubensky, I. A.; Vortmeyer, A. O.; Kim, S.; Lonser, R. R.; Park, D. M.; Ikejiri, B.; Li, J.; Okamoto, H.; Walbridge, S.; Ryschkewitsch, C.; Major, E.; Oldfield, E. H.; Zhuang, Z. Identification of tumor precursor cells in the brains of primates with radiation-induced de novo glioblastoma multiforme. Cell Cycle 16:452-456; 2006.
26. McLeod, M.; Hong, M.; Sen, A.; Sadi, D.; Ulalia, R.; Behie, L. A.; Mendez, I. Transplantation of bioreactor-produced neural stem cells into the rodent brain. Cell Transplant. 15:689-697; 2006.
27. Miqueli, A. D.; Rolff, J.; Lemm, M.; Fichtner, I.; Perez, R.; Montero, E. Radiosensitisation of U87MG brain tumors by anti-epidermal growth factor receptor monoclonal antibodies. Br. J. Cancer 100:950-958; 2009.
28. Oka, N.; Soeda, A.; Inagaki, A.; Onodera, M.; Maruyama, H.; Hara, A.; Kunisada, T.; Mori, H.; Iwama, T. VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells. Biochem. Biophys. Res. Commun. 360:553-559; 2007.
29. Oka, N.; Soeda, A.; Noda, S.; Iwama, T. Brain tumor stem cell from an adenoid glioblastoma multiforme. Neurol. Med. Chir. 49:146-151; 2009.
30. Okamoto, O. K.; Oba-Shinjo, S. M.; Lopes, L.; Nagahashi Marie, S. K. Expression of HOXC9 and E2F2 are upregulated in CD 133+ cells isolated from human astrocytomas and associated with transformation of human astrocytes. Biochim. Biophys. Acta 1769:437-442; 2007.
31. Perez Castillo, A.; Aguilar-Morante, D.; Morales-Garcia, J. A.; Dorado, J. Cancer stem cell and brain tumors. Clin. Transl. Oncol. 10:262-267; 2008.
32. Piccirillo, S. G.; Combi, R.; Cajola, L.; Patrizi, A.; Redaelli, S.; Bentivegna, A.; Baronchelli, S.; Maira, G.; Pollo, B.; Mangiola, A.; Dimeco, F.; Dalpra, L.; Vescovi, A. L. Distinct pools of cancer stem-like cells coexist within human glioblastoma and display different tumorigenicity and independent genomic evolution. Oncogene 28:1807-1811; 2009.
33. Piccirillo, S. G.; Reynolds, B. A.; Zanetti, N.; Lamorte, G.; Binda, E.; Broggi, G.; Brem, H.; Olivi, A.; Dimeco, F.; Vescovi, A. L. Bone morphogenetic proteins inhibit the tumorigenic potential of humane tumor initialing cells. Nature 444:761-765; 2006.
34. Sakariassen, P. O.; Immervoll, H.; Chekenya, M. Cancer stem cells as mediators of treatment resistance in brain tumors: Status and controversies. Neoplasm 9:882-892; 2007.
35. Silber, J.; Lim, D. A.; Petritsch, C.; Persson, A. I.; Maunakea, A. K.; Yu, M.; Vandenberg, S. R.; Ginzinger, D. G.; James, C. D.; Costello, J. F.; Bergers, G.; Weiss, W. A.; Alvarez-Buylla, A.; Hodgson, J. G. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 6:14; 2007.
36. Singh, S. K.; Hawkins, C.; Clarke, I. D.; Squire, J. A.; Bayani, J.; Hide, T.; Henkelman, R. M.; Cusimano, M. D.; Dirks, P. B. Identification of human brain tumor initiating cells. Nature 432:396-401; 2004.
37. Surawicz, T. S.; Davis, F.; Frells, S.; Laws, Jr., E. R.; Menck, H. R. Brain tumor survival: Results from the National Cancer Data Base. J. Neurooncol. 40:151-160; 1998.
38. Thon, N.; Damianoff, K.; Hegermann, J.; Grau, S.; Krebs, B.; Schnell, O.; Tonn, J. C.; Goldbrunner, R. Presence of pluripotent CD133+ cell correlates with malignancy of gliomas. Mol. Cell. Neurosci. 43:51-59; 2010.
39. Tunici, P.; Irvin, D.; Liu, G.; Yuan, X.; Zhaohui, Z.; Ng, H.; Yu, J. S. Brain tumor stem cells: New targets for clinical treatments? Neurosurg. Focus 26:E27; 2006.
40. Wen, P. Y.; Kesari, S. Malignant gliomas in adults. N. Engl. J. Med. 359:492-507; 2008.
41. Yang, X. F. Immunology of stem cells and cancer stem cells. Cell. Mol. Immunol. 4:161-171; 2007.
42. Yuan, X.; Curtin, J.; Xiong, Y.; Liu, G.; Waschsmann-Hogiu, S.; Farkas, D. L.; Black, K. L.; Yu, J. S. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23:9392-9400; 2004.
43. Ziche, M.; Jones, J.; Gullino, P. M. Role of prostaglandin E1 and cooper in angiogenesis. J. Natl. Cancer Inst. 69: 475-482; 1982.